Frito-Lay, a PepsiCo subsidiary, has initiated a voluntary recall of thousands of Doritos Nacho Cheese Tortilla Chips due to undeclared allergens - wheat and soy, potentially endangering sensitive consumers. The affected chips, primarily distributed in Pennsylvania, have been on sale since late June.
According to The New York Post, Frito-Lay is recalling thousands of Doritos Nacho Cheese Tortilla Chips as they may have undeclared ingredients of soy and wheat, which the Centers for Disease Control and Prevention (CDC) said are among the most common foods that cause severe allergic reactions in the United States.
The CDC said that the symptoms and severity of allergic reactions depend on one person to another, and the result can also change over time. One of the most serious results is Anaphylaxis which can happen mere minutes after consuming the allergen. In the worst-case scenario, exposure to the allergen can lead to death.
Fortunately, neither the Food and Drug Administration (FDA) nor Frito-Lay received any allergic reaction report related to the recall of Doritos Nacho Cheese chips. Still, consumers are being warned to stop eating and discard the affected chips immediately. People who are allergic or sensitive to wheat and soy are at risk of falling ill if they consume the products.
The Frito-Lay’s Doritos Nacho Cheese in 14.5 ounces and 1-ounce bag packaging are affected in this recall. These were distributed in retail stores and other outlets in Pennsylvania. The chips are said to have been available for sale since June 29. All in all, it was estimated that less than 7,000 bags of Doritos are being called back.
“The products covered by this recall were distributed at retail stores only in Pennsylvania and other outlets, such as food service locations and vending machines. Consumers would have been able to purchase the chips as early as June 29, 2023,” the FDA stated in the first allergen alert posted earlier this week. “No other Frito-Lay or Doritos products, flavors, sizes, or variety packs are recalled.”
Photo by: Gaining Visuals/Unsplash


Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
Asian Currencies Subdued as Yen Weakens Ahead of Fed, BOJ Decisions
Kioxia Rules Out SK Hynix Manufacturing Partnership
Anthropic Drops $6 Billion Decart AI Acquisition Talks
Iraq Seeks 6 Million Bpd OPEC+ Oil Quota
Nvidia Plans 2GW Australia AI Data Center Expansion by 2027
US Treasury Yields Near 5% as Oil Fuels Inflation Fears
OpenAI Targets Specialized Industries as Enterprise AI Demand Grows
Trump Threatens Bombardier U.S. Sales Ban
Gold Prices Steady Ahead of U.S. Inflation Data and Fed Decision
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
BOJ Set to Raise Rates to 1.25% as Inflation Risks Build
Gulf Ministers to Meet Iran in Oman Over Hormuz Shipping Deal
Gold Prices Rebound as Dollar Weakens, Fed Decision Looms
Oil Prices Surge as Middle East Shipping Attacks Threaten Supply 



